Puma regulatory exec resigns as neratinib panel nears

Puma Biotechnology Inc. (NASDAQ:PBYI) sank $4.70 (13%) to $31.85 in early after-hours trading on Thursday after it disclosed in an SEC filing that SVP of Regulatory Affairs and Project Management Robert Charnas will resign on May 15.

Charnas, who joined Puma on July 1, 2016, will leave the company due to health reasons. ...